A Randomized, Double-Blind, Cross-Over, Phase IV Trial of Oros-Methylphenidate (CONCERTA®) and Generic Novo-Methylphenidate ER-C (NOVO-generic)

Therapeutic Advances in Psychopharmacology
doi 10.1177/2045125316643674
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Sustained-Release Methylphenidate in Methamphetamine Dependence Treatment: A Double-Blind and Placebo-Controlled Trial

DARU, Journal of Pharmaceutical Sciences
MedicineDrug DiscoveryPharmacology
2015English

Safety and Tolerability of Virucidal Hand Rubs: A Randomized, Double-Blind, Cross-Over Trial

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2011English

Divergence by ADHD Subtype in Smoking Cessation Response to OROS-Methylphenidate

Nicotine and Tobacco Research
EnvironmentalPublic HealthOccupational Health
2011English

Social Adjustment and Family Function After Drug Switch From IR -Methylphenidate to OROS-methylphenidate in Patients With Attention-Deficit/Hyperactivity Disorder

Neuropsychiatric Disease and Treatment
2018English

Methylphenidate and Dyslipidemia

2012English

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Neurology
Neurology
2015English

Morphine Interaction With Prasugrel: A Double-Blind, Cross-Over Trial in Healthy Volunteers

Clinical Research in Cardiology
MedicineCardiovascular MedicineCardiology
2015English

Impact of Long-Term Treatment With OROS Methylphenidate on Pubertal Development in Adolescents With ADHD

Open Journal of Psychiatry
2014English

Treatment of Obese Non-Diabetic Patients With Phenformin. A Double-Blind Cross-Over Trial

BMJ
1970English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy